Actualités EURACAN | Informations sur les Cancers Rares en Europe

Padua to Host International Masterclass on Advances in Brain Tumor Treatment

On 22 June 2026, leading international experts in neuro-oncology will gather in Padua, Italy, for the Padua Masterclass in Advances in the Management of Primary Brain Tumors, an educational event dedicated to the latest developments in brain tumor research and treatment.

Strengthening Collaboration in Rare Cancers: EURACAN at the ESMO Sarcoma and Rare Cancers Congress 2026

From 12–14 March 2026, the international sarcoma and rare cancer community gathered in Lugano for the ESMO Sarcoma and Rare Cancers Congress 2026, one of the leading scientific meetings dedicated to these often under-represented tumour types.

Today is Rare Disease Day !

We stand together to recognise the millions of people across Europe and worldwide living with rare diseases — including rare cancers.

Call to Action for the rare cancer & rare disease community

We invite all ERN members to endorse and sign the Declaration on a European Innovation and Care Ecosystem for Rare and Complex Diseases, launched during the High Level Meeting for Rare and Complex Diseases (HLM Rare) in December 2025.

Webinar: Improving Rare Disease Care in Ukraine: Access to ERNs and Expert Resources

This joint webinar will explore how Ukrainian clinicians and patient representatives can collaborate with European Reference Networks (ERNs) to strengthen rare disease care.

ESMO Sarcoma & Rare Cancers Congress 2026 — Lugano, Switzerland

The European Society for Medical Oncology (ESMO) will host the ESMO Sarcoma and Rare Cancers Congress 2026 in Lugano, Switzerland, from 12–14 March 2026, bringing together leading clinicians, researchers and cancer experts from across Europe and beyond.

Season's greetings

Season’s Greetings from EURACAN ✨ As the year comes to a close, we would like to thank all our members, partners, healthcare professionals, patient representatives, and collaborators for their engagement and commitment to improving care for patients with rare adult solid cancers across Europe.

First-ever Continuous Monitoring Report for the ERNs available now!

The European Commission has published the first-ever Continuous Monitoring Report for the ERNs, confirming a 160% increase in new patients referred to ERN centres between 2018 and 2024.

First annual meeting of EUnetCCC - European Network of Comprehensive Cancer Centres in Paris!

We are proud to take part in this landmark gathering — the largest European initiative in healthcare — bringing together leading Comprehensive Cancer Centres (CCCs) across Europe with one shared mission: To build a strong and connected network of Comprehensive Cancer Centres across Europe by 2028.